E.J.M. van Leent

SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis

Thomas A. Luger, E.J.M. van Leent, Michael Graeber et al. · British Journal of Dermatology · 2001 · 244 citations · Full text

Medicine, Dermatology, Pharmacology +13

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis

Sakari Reitamo, E.J.M. van Leent, Vincent Ho et al. · Journal of Allergy and Clinical Immunology · 2002 · 238 citations

Medicine, Dermatology, Pediatrics +16

Low Systemic Exposure after Repeated Topical Application of Pimecrolimus (Elidel<sup>®</sup>, SD Z ASM 981) in Patients with Atopic Dermatitis

E.J.M. van Leent, Marie-Eve Ebelin, P Burtin et al. · Dermatology · 2002 · 114 citations

Medicine, Dermatology, Pharmacology +16

Randomized comparison of the type 4 phosphodiesterase inhibitor cipamfylline cream, cream vehicle and hydrocortisone 17-butyrate cream for the treatment of atopic dermatitis

C.E.M. Griffiths, E.J.M. van Leent, Martin Gilbert et al. · British Journal of Dermatology · 2002 · 50 citations

Medicine, Dermatology, Pharmacology +11

Effectiveness of a Risk-Based Visitor-Prioritizing System at a Sexually Transmitted Infection Outpatient Clinic

Titia Heijman, Akke K. van der Bij, Henry J.C. de Vries et al. · Sexually Transmitted Diseases · 2006 · 46 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +17